Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Models, Statistical | 28 | 2024 | 5074 | 3.080 |
Why?
|
Research Design | 24 | 2023 | 6174 | 2.390 |
Why?
|
Obesity, Morbid | 12 | 2024 | 1276 | 1.440 |
Why?
|
Epidemiologic Research Design | 6 | 2021 | 368 | 1.290 |
Why?
|
Cluster Analysis | 8 | 2023 | 2703 | 1.260 |
Why?
|
Computer Simulation | 24 | 2024 | 6233 | 1.120 |
Why?
|
Statistics as Topic | 5 | 2021 | 2358 | 1.110 |
Why?
|
Selection Bias | 4 | 2021 | 359 | 1.060 |
Why?
|
Pre-Eclampsia | 4 | 2024 | 1230 | 1.040 |
Why?
|
Electronic Health Records | 9 | 2022 | 4810 | 1.030 |
Why?
|
Bariatric Surgery | 9 | 2024 | 992 | 1.010 |
Why?
|
Bayes Theorem | 8 | 2024 | 2327 | 0.990 |
Why?
|
Data Interpretation, Statistical | 8 | 2019 | 2689 | 0.970 |
Why?
|
Sample Size | 9 | 2023 | 838 | 0.920 |
Why?
|
Biometry | 4 | 2022 | 561 | 0.880 |
Why?
|
Gastric Bypass | 7 | 2021 | 818 | 0.870 |
Why?
|
Endpoint Determination | 2 | 2016 | 590 | 0.860 |
Why?
|
Mammography | 12 | 2016 | 2430 | 0.820 |
Why?
|
Weight Loss | 7 | 2021 | 2682 | 0.780 |
Why?
|
Death | 2 | 2017 | 674 | 0.780 |
Why?
|
Data Collection | 7 | 2023 | 3316 | 0.750 |
Why?
|
Gastrectomy | 4 | 2021 | 671 | 0.730 |
Why?
|
Alkaptonuria | 1 | 2020 | 13 | 0.700 |
Why?
|
Paternal Exposure | 1 | 2020 | 96 | 0.690 |
Why?
|
Program Evaluation | 3 | 2019 | 2486 | 0.680 |
Why?
|
Premature Birth | 5 | 2024 | 1782 | 0.640 |
Why?
|
Birth Weight | 3 | 2021 | 2101 | 0.630 |
Why?
|
Dementia | 9 | 2021 | 2686 | 0.610 |
Why?
|
Humans | 195 | 2024 | 760740 | 0.600 |
Why?
|
Epidemiologic Methods | 6 | 2021 | 1335 | 0.600 |
Why?
|
Infant, Low Birth Weight | 3 | 2024 | 869 | 0.600 |
Why?
|
Parenting | 7 | 2022 | 702 | 0.590 |
Why?
|
Epidemiologic Studies | 1 | 2020 | 673 | 0.570 |
Why?
|
Infant Mortality | 6 | 2024 | 751 | 0.560 |
Why?
|
Research | 2 | 2020 | 1977 | 0.550 |
Why?
|
Patient Readmission | 4 | 2018 | 3269 | 0.540 |
Why?
|
Pregnancy Outcome | 4 | 2024 | 2921 | 0.540 |
Why?
|
Case-Control Studies | 9 | 2020 | 22153 | 0.500 |
Why?
|
Comparative Effectiveness Research | 3 | 2019 | 708 | 0.490 |
Why?
|
Rare Diseases | 1 | 2020 | 622 | 0.470 |
Why?
|
Actigraphy | 3 | 2022 | 522 | 0.440 |
Why?
|
Logistic Models | 11 | 2017 | 13248 | 0.440 |
Why?
|
Maternal Exposure | 1 | 2020 | 1067 | 0.440 |
Why?
|
North Carolina | 5 | 2014 | 322 | 0.430 |
Why?
|
Female | 113 | 2024 | 392203 | 0.430 |
Why?
|
Birth Rate | 1 | 2014 | 168 | 0.430 |
Why?
|
Papillomavirus Vaccines | 4 | 2023 | 496 | 0.410 |
Why?
|
Probability | 4 | 2023 | 2475 | 0.410 |
Why?
|
Sleep | 10 | 2022 | 4764 | 0.410 |
Why?
|
Malawi | 3 | 2019 | 302 | 0.400 |
Why?
|
Risk Factors | 37 | 2024 | 74128 | 0.400 |
Why?
|
Sexual Behavior | 10 | 2024 | 2187 | 0.380 |
Why?
|
Likelihood Functions | 4 | 2022 | 991 | 0.370 |
Why?
|
Clinical Trials as Topic | 5 | 2021 | 7995 | 0.370 |
Why?
|
Weight Gain | 3 | 2022 | 2349 | 0.360 |
Why?
|
Health Facilities | 4 | 2024 | 578 | 0.360 |
Why?
|
Kidney Failure, Chronic | 3 | 2021 | 2474 | 0.360 |
Why?
|
Cause of Death | 4 | 2019 | 3683 | 0.360 |
Why?
|
Ecology | 2 | 2008 | 103 | 0.360 |
Why?
|
Alzheimer Disease | 8 | 2024 | 8603 | 0.360 |
Why?
|
Infant, Newborn | 19 | 2024 | 26183 | 0.350 |
Why?
|
Anti-Retroviral Agents | 3 | 2019 | 1783 | 0.350 |
Why?
|
Biostatistics | 1 | 2011 | 163 | 0.340 |
Why?
|
Graft vs Host Disease | 2 | 2019 | 3026 | 0.330 |
Why?
|
Proportional Hazards Models | 12 | 2024 | 12448 | 0.330 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2018 | 1894 | 0.320 |
Why?
|
Renal Dialysis | 1 | 2018 | 1795 | 0.310 |
Why?
|
Homosexuality, Female | 4 | 2024 | 171 | 0.310 |
Why?
|
Small-Area Analysis | 1 | 2008 | 52 | 0.310 |
Why?
|
Aged | 56 | 2024 | 169092 | 0.300 |
Why?
|
Autopsy | 2 | 2009 | 1008 | 0.300 |
Why?
|
Biomedical Research | 3 | 2023 | 3426 | 0.300 |
Why?
|
Adult | 64 | 2024 | 220995 | 0.300 |
Why?
|
Heterosexuality | 4 | 2024 | 309 | 0.290 |
Why?
|
Ethiopia | 6 | 2024 | 460 | 0.290 |
Why?
|
Longitudinal Studies | 18 | 2024 | 14599 | 0.290 |
Why?
|
Survival Analysis | 4 | 2024 | 10072 | 0.290 |
Why?
|
Pregnancy | 18 | 2024 | 29869 | 0.280 |
Why?
|
HIV Infections | 8 | 2019 | 17342 | 0.280 |
Why?
|
Parents | 7 | 2023 | 3563 | 0.280 |
Why?
|
Stroke | 4 | 2023 | 9715 | 0.270 |
Why?
|
Time | 2 | 2009 | 545 | 0.270 |
Why?
|
Papillomavirus Infections | 4 | 2023 | 1612 | 0.270 |
Why?
|
Breast Neoplasms | 13 | 2017 | 20988 | 0.270 |
Why?
|
Decision Making | 1 | 2020 | 3919 | 0.270 |
Why?
|
Male | 78 | 2024 | 360402 | 0.270 |
Why?
|
Washington | 7 | 2017 | 315 | 0.270 |
Why?
|
Regression Analysis | 4 | 2018 | 6339 | 0.270 |
Why?
|
California | 2 | 2021 | 1431 | 0.260 |
Why?
|
Prenatal Care | 4 | 2024 | 1140 | 0.260 |
Why?
|
Risk Assessment | 12 | 2024 | 23974 | 0.260 |
Why?
|
Sexual Partners | 2 | 2024 | 800 | 0.250 |
Why?
|
Disease Outbreaks | 1 | 2015 | 1748 | 0.250 |
Why?
|
United States | 38 | 2024 | 72292 | 0.250 |
Why?
|
Prostatic Neoplasms | 7 | 2024 | 11107 | 0.240 |
Why?
|
Patient Acceptance of Health Care | 7 | 2019 | 3196 | 0.240 |
Why?
|
Patient Selection | 4 | 2019 | 4237 | 0.240 |
Why?
|
Young Adult | 26 | 2024 | 59191 | 0.240 |
Why?
|
Delivery, Obstetric | 2 | 2024 | 939 | 0.240 |
Why?
|
Middle Aged | 47 | 2024 | 220603 | 0.240 |
Why?
|
Antidepressive Agents | 2 | 2016 | 2896 | 0.230 |
Why?
|
Registries | 9 | 2021 | 8209 | 0.230 |
Why?
|
Stillbirth | 2 | 2024 | 368 | 0.230 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2019 | 5671 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 10203 | 0.220 |
Why?
|
Vaccination | 5 | 2023 | 3370 | 0.210 |
Why?
|
Public Health | 1 | 2016 | 2671 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 8 | 2021 | 12143 | 0.210 |
Why?
|
Bisexuality | 3 | 2024 | 294 | 0.210 |
Why?
|
Health Status Disparities | 5 | 2024 | 1846 | 0.200 |
Why?
|
Sampling Studies | 2 | 2020 | 615 | 0.200 |
Why?
|
Infant | 18 | 2024 | 36157 | 0.200 |
Why?
|
Fathers | 2 | 2021 | 375 | 0.200 |
Why?
|
Cohort Studies | 23 | 2024 | 41464 | 0.200 |
Why?
|
Cerebrovascular Disorders | 2 | 2019 | 1474 | 0.190 |
Why?
|
Live Birth | 2 | 2022 | 510 | 0.190 |
Why?
|
Self-Examination | 2 | 2019 | 71 | 0.190 |
Why?
|
Observer Variation | 5 | 2024 | 2607 | 0.190 |
Why?
|
Virus Shedding | 1 | 2022 | 109 | 0.190 |
Why?
|
Propensity Score | 2 | 2019 | 1912 | 0.190 |
Why?
|
Benzodiazepines | 2 | 2024 | 1133 | 0.190 |
Why?
|
Adolescent | 24 | 2024 | 88247 | 0.190 |
Why?
|
Aged, 80 and over | 22 | 2024 | 58919 | 0.180 |
Why?
|
Survivors | 4 | 2024 | 2373 | 0.180 |
Why?
|
Recurrence | 4 | 2023 | 8426 | 0.180 |
Why?
|
Child | 25 | 2024 | 80089 | 0.180 |
Why?
|
Retrospective Studies | 24 | 2024 | 80583 | 0.180 |
Why?
|
Reproducibility of Results | 11 | 2021 | 20077 | 0.180 |
Why?
|
Obesity | 6 | 2023 | 12934 | 0.180 |
Why?
|
Algorithms | 4 | 2017 | 14024 | 0.170 |
Why?
|
Medicare | 5 | 2024 | 6774 | 0.170 |
Why?
|
Disease Progression | 3 | 2016 | 13495 | 0.170 |
Why?
|
Cyclonic Storms | 1 | 2022 | 116 | 0.170 |
Why?
|
Bullying | 1 | 2023 | 232 | 0.170 |
Why?
|
Sensitivity and Specificity | 11 | 2016 | 14649 | 0.170 |
Why?
|
Mass Screening | 7 | 2012 | 5425 | 0.170 |
Why?
|
Causality | 3 | 2023 | 1241 | 0.170 |
Why?
|
Electric Injuries | 1 | 2019 | 24 | 0.170 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2024 | 496 | 0.170 |
Why?
|
Prospective Studies | 23 | 2024 | 54364 | 0.170 |
Why?
|
Early Detection of Cancer | 6 | 2019 | 3196 | 0.170 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2020 | 130 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 413 | 0.160 |
Why?
|
Crime Victims | 1 | 2023 | 347 | 0.160 |
Why?
|
Apolipoproteins | 1 | 2021 | 326 | 0.160 |
Why?
|
Growth Disorders | 1 | 2024 | 634 | 0.160 |
Why?
|
Apolipoproteins E | 3 | 2021 | 1443 | 0.160 |
Why?
|
Odds Ratio | 4 | 2022 | 9644 | 0.160 |
Why?
|
Heart Failure | 3 | 2019 | 11670 | 0.160 |
Why?
|
Depression | 2 | 2016 | 8132 | 0.160 |
Why?
|
Patient Dropouts | 1 | 2021 | 410 | 0.160 |
Why?
|
Professional Competence | 2 | 2014 | 431 | 0.150 |
Why?
|
Rwanda | 1 | 2021 | 656 | 0.150 |
Why?
|
Tanzania | 3 | 2019 | 1390 | 0.150 |
Why?
|
Minority Groups | 2 | 2021 | 1202 | 0.150 |
Why?
|
Lymphoma | 1 | 2007 | 1899 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2024 | 517 | 0.150 |
Why?
|
Colorectal Neoplasms | 2 | 2016 | 6927 | 0.150 |
Why?
|
Body Mass Index | 10 | 2024 | 12942 | 0.150 |
Why?
|
Neoplasms | 4 | 2024 | 22131 | 0.150 |
Why?
|
Maternal Health Services | 2 | 2024 | 460 | 0.150 |
Why?
|
Pneumonia | 2 | 2020 | 2143 | 0.150 |
Why?
|
Tsunamis | 1 | 2018 | 61 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.140 |
Why?
|
Socioeconomic Factors | 8 | 2022 | 7805 | 0.140 |
Why?
|
Social Isolation | 1 | 2020 | 365 | 0.140 |
Why?
|
Malnutrition | 1 | 2024 | 622 | 0.140 |
Why?
|
Pandemics | 6 | 2023 | 8652 | 0.140 |
Why?
|
Aging | 4 | 2023 | 8700 | 0.140 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2024 | 4575 | 0.140 |
Why?
|
Health Services Research | 2 | 2021 | 1808 | 0.140 |
Why?
|
Physical Education and Training | 1 | 2017 | 102 | 0.140 |
Why?
|
Blood Glucose | 5 | 2013 | 6390 | 0.140 |
Why?
|
Treatment Outcome | 8 | 2021 | 64572 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2015 | 4010 | 0.130 |
Why?
|
Electric Countershock | 1 | 2019 | 532 | 0.130 |
Why?
|
Risk | 5 | 2021 | 9603 | 0.130 |
Why?
|
Editorial Policies | 1 | 2021 | 458 | 0.130 |
Why?
|
Clinical Competence | 1 | 2011 | 4790 | 0.130 |
Why?
|
National Health Programs | 1 | 2019 | 440 | 0.130 |
Why?
|
Sickness Impact Profile | 1 | 2017 | 299 | 0.130 |
Why?
|
Pneumococcal Infections | 1 | 2020 | 501 | 0.130 |
Why?
|
Pharmacoepidemiology | 1 | 2019 | 350 | 0.130 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5811 | 0.130 |
Why?
|
Earthquakes | 1 | 2018 | 191 | 0.130 |
Why?
|
Mothers | 5 | 2022 | 2194 | 0.130 |
Why?
|
Environmental Exposure | 2 | 2007 | 4483 | 0.120 |
Why?
|
Incidence | 12 | 2024 | 21339 | 0.120 |
Why?
|
Time Factors | 13 | 2022 | 39908 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 561 | 0.120 |
Why?
|
Child, Preschool | 13 | 2024 | 42193 | 0.120 |
Why?
|
Clinical Protocols | 2 | 2011 | 1436 | 0.120 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2017 | 370 | 0.120 |
Why?
|
Nurses | 1 | 2024 | 2477 | 0.120 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1250 | 0.120 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2020 | 0.120 |
Why?
|
Exercise | 4 | 2022 | 5886 | 0.120 |
Why?
|
Critical Illness | 2 | 2022 | 2709 | 0.120 |
Why?
|
Coronary Disease | 2 | 2019 | 5911 | 0.110 |
Why?
|
Bereavement | 1 | 2018 | 309 | 0.110 |
Why?
|
Follow-Up Studies | 13 | 2021 | 39062 | 0.110 |
Why?
|
Brain | 7 | 2022 | 27100 | 0.110 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1204 | 0.110 |
Why?
|
Publishing | 1 | 2021 | 832 | 0.110 |
Why?
|
Virus Replication | 1 | 2022 | 2427 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2020 | 846 | 0.110 |
Why?
|
Diet | 5 | 2023 | 8049 | 0.110 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2023 | 1187 | 0.110 |
Why?
|
Housing | 1 | 2018 | 669 | 0.110 |
Why?
|
Health Promotion | 3 | 2022 | 2206 | 0.110 |
Why?
|
Air Pollution | 1 | 2007 | 2355 | 0.110 |
Why?
|
Health Behavior | 3 | 2023 | 2643 | 0.110 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5334 | 0.110 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 803 | 0.110 |
Why?
|
Thyroid Gland | 1 | 2020 | 1170 | 0.110 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2020 | 846 | 0.110 |
Why?
|
Referral and Consultation | 3 | 2016 | 3599 | 0.100 |
Why?
|
Metformin | 1 | 2020 | 906 | 0.100 |
Why?
|
Reproductive Health Services | 1 | 2013 | 87 | 0.100 |
Why?
|
Sexuality | 1 | 2014 | 180 | 0.100 |
Why?
|
Circadian Clocks | 1 | 2014 | 164 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2188 | 0.100 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2016 | 662 | 0.100 |
Why?
|
Disasters | 1 | 2018 | 520 | 0.100 |
Why?
|
Gender Identity | 2 | 2017 | 765 | 0.100 |
Why?
|
False Positive Reactions | 2 | 2011 | 957 | 0.100 |
Why?
|
Sex Factors | 4 | 2024 | 10549 | 0.100 |
Why?
|
Pregnancy Complications | 2 | 2024 | 2948 | 0.100 |
Why?
|
Child Behavior Disorders | 1 | 2017 | 804 | 0.100 |
Why?
|
Postoperative Complications | 3 | 2024 | 15609 | 0.100 |
Why?
|
Puerto Rico | 2 | 2023 | 378 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36401 | 0.090 |
Why?
|
Viral Load | 2 | 2017 | 3325 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1551 | 0.090 |
Why?
|
Health Resources | 2 | 2015 | 934 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 362 | 0.090 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2011 | 119 | 0.090 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2015 | 549 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2024 | 1866 | 0.090 |
Why?
|
Women's Health | 1 | 2020 | 2066 | 0.090 |
Why?
|
Cognition Disorders | 3 | 2010 | 3979 | 0.090 |
Why?
|
Reoperation | 1 | 2021 | 4300 | 0.090 |
Why?
|
Adolescent Behavior | 1 | 2019 | 1188 | 0.090 |
Why?
|
Transsexualism | 1 | 2014 | 208 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20556 | 0.090 |
Why?
|
Infant, Premature | 1 | 2020 | 2107 | 0.090 |
Why?
|
User-Computer Interface | 1 | 2017 | 1397 | 0.090 |
Why?
|
Age Factors | 9 | 2015 | 18381 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2010 | 2270 | 0.080 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 1483 | 0.080 |
Why?
|
Emotions | 1 | 2022 | 2741 | 0.080 |
Why?
|
Histamine H2 Antagonists | 1 | 2011 | 165 | 0.080 |
Why?
|
Massage | 1 | 2009 | 86 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1727 | 0.080 |
Why?
|
Mortality | 4 | 2024 | 2899 | 0.080 |
Why?
|
Quality of Health Care | 2 | 2019 | 4325 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1999 | 0.080 |
Why?
|
Zidovudine | 2 | 2017 | 624 | 0.080 |
Why?
|
Brain Ischemia | 1 | 2022 | 3030 | 0.080 |
Why?
|
Electrical Equipment and Supplies | 1 | 2009 | 28 | 0.080 |
Why?
|
Caribbean Region | 2 | 2023 | 192 | 0.080 |
Why?
|
Melatonin | 1 | 2014 | 669 | 0.080 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 825 | 0.080 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1081 | 0.080 |
Why?
|
Patient Discharge | 2 | 2018 | 3442 | 0.080 |
Why?
|
Health Care Surveys | 1 | 2016 | 2422 | 0.080 |
Why?
|
Social Support | 1 | 2018 | 2174 | 0.080 |
Why?
|
Chronic Disease | 2 | 2022 | 9310 | 0.080 |
Why?
|
Cardiovascular Diseases | 4 | 2023 | 15498 | 0.080 |
Why?
|
Neurofibrillary Tangles | 1 | 2010 | 457 | 0.070 |
Why?
|
Life Expectancy | 1 | 2015 | 1242 | 0.070 |
Why?
|
Latin America | 2 | 2023 | 407 | 0.070 |
Why?
|
Comorbidity | 2 | 2021 | 10507 | 0.070 |
Why?
|
Dementia, Vascular | 1 | 2009 | 122 | 0.070 |
Why?
|
Remission Induction | 3 | 2024 | 2391 | 0.070 |
Why?
|
Diabetes Mellitus | 5 | 2013 | 5838 | 0.070 |
Why?
|
Ohio | 1 | 2008 | 322 | 0.070 |
Why?
|
Mental Health | 1 | 2022 | 3253 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3303 | 0.070 |
Why?
|
Choice Behavior | 1 | 2013 | 825 | 0.070 |
Why?
|
Pneumonectomy | 1 | 2014 | 1119 | 0.070 |
Why?
|
Environmental Pollution | 1 | 2008 | 124 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2252 | 0.070 |
Why?
|
Quality of Life | 3 | 2024 | 13359 | 0.070 |
Why?
|
Linear Models | 3 | 2023 | 5866 | 0.070 |
Why?
|
Prevalence | 7 | 2024 | 15702 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2013 | 1315 | 0.070 |
Why?
|
Feeding Behavior | 3 | 2023 | 3183 | 0.070 |
Why?
|
Health Policy | 1 | 2018 | 2682 | 0.070 |
Why?
|
Lewy Body Disease | 1 | 2009 | 254 | 0.070 |
Why?
|
Violence | 2 | 2023 | 936 | 0.070 |
Why?
|
Vietnam | 2 | 2017 | 406 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1896 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6807 | 0.060 |
Why?
|
Geography | 1 | 2008 | 652 | 0.060 |
Why?
|
Markov Chains | 2 | 2024 | 965 | 0.060 |
Why?
|
Thinking | 1 | 2009 | 319 | 0.060 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 4910 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2009 | 2925 | 0.060 |
Why?
|
Calcium Channel Blockers | 1 | 2008 | 694 | 0.060 |
Why?
|
Social Environment | 2 | 2021 | 1021 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 5319 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2315 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2013 | 1375 | 0.060 |
Why?
|
Alprazolam | 1 | 2024 | 103 | 0.060 |
Why?
|
Anti-HIV Agents | 2 | 2017 | 4524 | 0.060 |
Why?
|
Bone Density | 1 | 2017 | 3548 | 0.060 |
Why?
|
Iceland | 2 | 2014 | 184 | 0.060 |
Why?
|
ROC Curve | 3 | 2020 | 3575 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5369 | 0.060 |
Why?
|
Cross-Over Studies | 2 | 2022 | 2079 | 0.060 |
Why?
|
Lorazepam | 1 | 2024 | 155 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3801 | 0.060 |
Why?
|
Fetal Macrosomia | 1 | 2024 | 141 | 0.060 |
Why?
|
Starch | 1 | 2023 | 79 | 0.050 |
Why?
|
Mental Disorders | 2 | 2021 | 6826 | 0.050 |
Why?
|
Lung Neoplasms | 3 | 2014 | 13383 | 0.050 |
Why?
|
Monte Carlo Method | 2 | 2023 | 1257 | 0.050 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26065 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6345 | 0.050 |
Why?
|
Vulnerable Populations | 1 | 2008 | 705 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Child Mortality | 1 | 2024 | 199 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 3708 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5493 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1517 | 0.050 |
Why?
|
Survival Rate | 2 | 2024 | 12719 | 0.050 |
Why?
|
Infant, Small for Gestational Age | 1 | 2024 | 462 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3805 | 0.050 |
Why?
|
Patient Compliance | 1 | 2011 | 2688 | 0.050 |
Why?
|
Multilevel Analysis | 1 | 2021 | 145 | 0.050 |
Why?
|
Low Back Pain | 1 | 2009 | 982 | 0.050 |
Why?
|
Outpatients | 1 | 2009 | 1596 | 0.050 |
Why?
|
Ecuador | 1 | 2020 | 62 | 0.050 |
Why?
|
Vehicle Emissions | 1 | 2006 | 655 | 0.050 |
Why?
|
Resource Allocation | 1 | 2023 | 350 | 0.050 |
Why?
|
Radiology | 1 | 2014 | 2113 | 0.040 |
Why?
|
Bibliometrics | 1 | 2023 | 352 | 0.040 |
Why?
|
Hospitalization | 3 | 2020 | 10708 | 0.040 |
Why?
|
Kenya | 1 | 2022 | 757 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2023 | 339 | 0.040 |
Why?
|
Child, Hospitalized | 1 | 2021 | 182 | 0.040 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2894 | 0.040 |
Why?
|
Maternal Age | 1 | 2022 | 809 | 0.040 |
Why?
|
Parity | 1 | 2022 | 924 | 0.040 |
Why?
|
Neck | 1 | 2024 | 734 | 0.040 |
Why?
|
Family | 2 | 2021 | 3193 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2024 | 7390 | 0.040 |
Why?
|
Antihypertensive Agents | 1 | 2008 | 2018 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 2020 | 328 | 0.040 |
Why?
|
Residence Characteristics | 3 | 2014 | 2092 | 0.040 |
Why?
|
Home Childbirth | 1 | 2019 | 54 | 0.040 |
Why?
|
Self Report | 2 | 2021 | 3727 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2009 | 7050 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2021 | 15250 | 0.040 |
Why?
|
Medicaid | 2 | 2023 | 2814 | 0.040 |
Why?
|
Life Style | 2 | 2021 | 3907 | 0.040 |
Why?
|
Pregnant Women | 1 | 2023 | 567 | 0.040 |
Why?
|
Stavudine | 1 | 2017 | 85 | 0.040 |
Why?
|
Head | 1 | 2024 | 922 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 504 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11458 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4058 | 0.040 |
Why?
|
Vegetables | 1 | 2023 | 1192 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2022 | 811 | 0.040 |
Why?
|
Culture | 1 | 2021 | 623 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1229 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2022 | 761 | 0.040 |
Why?
|
Graft Survival | 1 | 2007 | 3814 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2009 | 3245 | 0.030 |
Why?
|
Community-Based Participatory Research | 1 | 2019 | 221 | 0.030 |
Why?
|
Alkynes | 1 | 2017 | 320 | 0.030 |
Why?
|
Pneumococcal Vaccines | 1 | 2020 | 397 | 0.030 |
Why?
|
Beverages | 1 | 2022 | 821 | 0.030 |
Why?
|
Psychometrics | 2 | 2021 | 3062 | 0.030 |
Why?
|
Nevirapine | 1 | 2017 | 273 | 0.030 |
Why?
|
Educational Status | 2 | 2015 | 2509 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12966 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 2 | 2017 | 2567 | 0.030 |
Why?
|
Cognition | 2 | 2024 | 6988 | 0.030 |
Why?
|
Maternal Mortality | 1 | 2019 | 301 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2017 | 432 | 0.030 |
Why?
|
Femur Neck | 1 | 2017 | 314 | 0.030 |
Why?
|
Benzoxazines | 1 | 2017 | 316 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2009 | 3356 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5430 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2022 | 12043 | 0.030 |
Why?
|
Pain | 2 | 2023 | 5062 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9277 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8532 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11735 | 0.030 |
Why?
|
Employment | 1 | 2022 | 1113 | 0.030 |
Why?
|
Parturition | 1 | 2019 | 447 | 0.030 |
Why?
|
Pamphlets | 1 | 2015 | 71 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1518 | 0.030 |
Why?
|
Polysomnography | 1 | 2022 | 1852 | 0.030 |
Why?
|
Office Visits | 1 | 2019 | 593 | 0.030 |
Why?
|
Dermoscopy | 1 | 2015 | 66 | 0.030 |
Why?
|
Diabetic Neuropathies | 1 | 2018 | 405 | 0.030 |
Why?
|
Telepathology | 1 | 2015 | 77 | 0.030 |
Why?
|
Portugal | 1 | 2014 | 91 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 7963 | 0.030 |
Why?
|
Graft Rejection | 1 | 2007 | 4438 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1386 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3351 | 0.030 |
Why?
|
Infant, Premature, Diseases | 1 | 2020 | 710 | 0.030 |
Why?
|
Japan | 1 | 2018 | 1372 | 0.030 |
Why?
|
Contraception Behavior | 1 | 2015 | 180 | 0.030 |
Why?
|
Amygdala | 1 | 2021 | 1353 | 0.030 |
Why?
|
Counseling | 1 | 2021 | 1538 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2805 | 0.030 |
Why?
|
Microcirculation | 1 | 2018 | 1272 | 0.030 |
Why?
|
Gestational Age | 1 | 2022 | 3577 | 0.030 |
Why?
|
Mianserin | 1 | 2013 | 51 | 0.030 |
Why?
|
Spain | 1 | 2014 | 487 | 0.030 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 410 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17878 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2011 | 5031 | 0.030 |
Why?
|
Breast Feeding | 1 | 2021 | 1355 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2007 | 4218 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2872 | 0.030 |
Why?
|
Paroxetine | 1 | 2013 | 182 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2022 | 2400 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2023 | 1937 | 0.020 |
Why?
|
Leadership | 1 | 2021 | 1385 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2018 | 972 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 634 | 0.020 |
Why?
|
Physicians | 1 | 2009 | 4583 | 0.020 |
Why?
|
Uganda | 1 | 2015 | 1332 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2789 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2019 | 6223 | 0.020 |
Why?
|
Social Class | 1 | 2019 | 1993 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3017 | 0.020 |
Why?
|
Biological Products | 1 | 2019 | 912 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2964 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2120 | 0.020 |
Why?
|
Fluoxetine | 1 | 2013 | 733 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2018 | 1274 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2014 | 970 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2175 | 0.020 |
Why?
|
Health Surveys | 2 | 2011 | 4036 | 0.020 |
Why?
|
Security Measures | 1 | 2009 | 82 | 0.020 |
Why?
|
Risk-Taking | 1 | 2014 | 1038 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2011 | 10754 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3879 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2277 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2017 | 1874 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9313 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3567 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3085 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2916 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4615 | 0.020 |
Why?
|
Poverty | 1 | 2019 | 2692 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3851 | 0.020 |
Why?
|
Asthma | 1 | 2006 | 6234 | 0.020 |
Why?
|
Fasting | 1 | 2013 | 1603 | 0.020 |
Why?
|
Alaska | 1 | 2006 | 70 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4472 | 0.020 |
Why?
|
Motivation | 1 | 2015 | 2003 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2010 | 1118 | 0.010 |
Why?
|
Professional-Patient Relations | 1 | 2009 | 724 | 0.010 |
Why?
|
Population Surveillance | 1 | 2014 | 2597 | 0.010 |
Why?
|
Psychotherapy | 1 | 2013 | 1648 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 3752 | 0.010 |
Why?
|
Geographic Information Systems | 1 | 2006 | 281 | 0.010 |
Why?
|
SEER Program | 1 | 2008 | 1450 | 0.010 |
Why?
|
Curriculum | 1 | 2017 | 3739 | 0.010 |
Why?
|
Suicide | 1 | 2014 | 1601 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2014 | 2569 | 0.010 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2011 | 940 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3094 | 0.010 |
Why?
|
Age of Onset | 1 | 2009 | 3303 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12661 | 0.010 |
Why?
|
Laparoscopy | 1 | 2013 | 2030 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2009 | 2378 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29601 | 0.010 |
Why?
|
Genetic Variation | 1 | 2014 | 6561 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12977 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 2164 | 0.010 |
Why?
|
Insurance, Health | 1 | 2011 | 2495 | 0.010 |
Why?
|
Image Enhancement | 1 | 2009 | 2881 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6763 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2011 | 3743 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2009 | 3115 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6593 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30015 | 0.010 |
Why?
|
Smoking | 1 | 2013 | 9054 | 0.010 |
Why?
|
Primary Health Care | 1 | 2013 | 4677 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2004 | 1780 | 0.010 |
Why?
|
Homosexuality, Male | 1 | 2004 | 1333 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15908 | 0.010 |
Why?
|
Blood Pressure | 1 | 2009 | 8473 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15829 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168202 | 0.010 |
Why?
|